Drug Profile


Alternative Names: LU 23174; S 1991; Serdolect; Serlect

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lundbeck A/S
  • Class Antipsychotics; Imidazoles; Indoles
  • Mechanism of Action Alpha 1 adrenergic receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Schizophrenia

Most Recent Events

  • 13 Aug 2010 Discontinued - Preregistration for Schizophrenia in USA (PO)
  • 25 Jun 2009 Lundbeck receives complete response letter from the US FDA for sertindole in Schizophrenia
  • 08 Apr 2009 Psychopharmacology Drug Advisory Committee issues an opinion on sertindole for Schizophrenia in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top